Date: Thursday, January 29th
Time: 10am – 11am CST | 4pm – 5pm GMT
Prof. Peter Hamilton | VP Research and Development,
PathXL Eileen Regan | Head of Account Management and Pre-Sales
Empower your research with the latest upgrade to our award winning automated tumor annotation and analysis software, TissueMark. Within this product range we have developed three separate automated methods to count % tumor nuclei in digital H&E stained tissue slides reducing variability associated with visual estimation.
This novel approach is invaluable in defining thresholds for tumor cell sufficiency in FFPE samples showing precision and reproducibility never before achieved with image analysis. This can support evaluation of sequence-based biomarkers such as EGFR, KRAS and BRAF, improve the efficiency of clinical trials which require solid tumor genomics, accelerate the discovery of new molecular biomarkers in solid tumors, or support the delivery of clinical sequencing.
In this 60 minute webinar, we will discuss these new methods and their validation accompanied by a live product demonstration of the TissueMark platform.
Please feel free to contact us if you would like to receive alerts about our upcoming webinars.
Let us know what you think via Twitter – #Pathxlwebinars
Category: Anatomic Pathology, Clinical Laboratories, Device Manufacturers, Digital Pathology News, Education, Histology, Marketing, Medical Research, Pathology News, Vendor products, Web/Tech, Webinars